Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · June 26, 2024

No Risk of Breast or Gynecologic Malignancies in Women Treated With Spironolactone for Dermatologic Conditions

Journal of the American Academy of Dermatology

 

Additional Info

Journal of the American Academy of Dermatology
No increased risk of breast or gynecologic malignancies in women exposed to spironolactone for dermatologic conditions: A retrospective cohort study
J Am Acad Dermatol 2024 Jun 01;90(6)1302-1304, RC Hill, Y Wang, B Shaikh, SR Lipner

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading